653 related articles for article (PubMed ID: 18799497)
21. Angiogenesis blockade as therapy for hepatocellular carcinoma: progress and challenges.
Hao CY
J Gastroenterol Hepatol; 2011 Jan; 26(1):4-6. PubMed ID: 21175786
[No Abstract] [Full Text] [Related]
22. The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer.
Bran B; Bran G; Hörmann K; Riedel F
Int J Oncol; 2009 Jan; 34(1):255-61. PubMed ID: 19082496
[TBL] [Abstract][Full Text] [Related]
23. [Vascular endothelial growth factor--structure and functions].
Barańska P; Jerczyńska H; Pawłowska Z
Postepy Biochem; 2005; 51(1):12-21. PubMed ID: 16209337
[TBL] [Abstract][Full Text] [Related]
24. Nerve growth factor as an angiogenic factor.
Nico B; Mangieri D; Benagiano V; Crivellato E; Ribatti D
Microvasc Res; 2008 Mar; 75(2):135-41. PubMed ID: 17764704
[TBL] [Abstract][Full Text] [Related]
25. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
Shojaei F; Ferrara N
Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
[TBL] [Abstract][Full Text] [Related]
26. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
Roscoe WA; Welsh ME; Carter DE; Karlik SJ
J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
[TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells.
Tamura K; Hashimoto K; Suzuki K; Yoshie M; Kutsukake M; Sakurai T
Eur J Pharmacol; 2009 May; 610(1-3):61-7. PubMed ID: 19374835
[TBL] [Abstract][Full Text] [Related]
28. Noninvasive tracer techniques to characterize angiogenesis.
Haubner R
Handb Exp Pharmacol; 2008; (185 Pt 2):323-39. PubMed ID: 18626609
[TBL] [Abstract][Full Text] [Related]
29. Hepatic microcirculation and cholangiocyte physiopathology.
Gaudio E; Onori P; Franchitto A; Pannarale L; Alpini G; Alvaro D
Ital J Anat Embryol; 2005; 110(2 Suppl 1):71-5. PubMed ID: 16101023
[TBL] [Abstract][Full Text] [Related]
30. Vascular changes in hepatocellular carcinoma.
Yang ZF; Poon RT
Anat Rec (Hoboken); 2008 Jun; 291(6):721-34. PubMed ID: 18484619
[TBL] [Abstract][Full Text] [Related]
31. VEGF and inhibitors of TGFbeta type-I receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression.
Liu Z; Kobayashi K; van Dinther M; van Heiningen SH; Valdimarsdottir G; van Laar T; Scharpfenecker M; Löwik CW; Goumans MJ; Ten Dijke P; Pardali E
J Cell Sci; 2009 Sep; 122(Pt 18):3294-302. PubMed ID: 19706683
[TBL] [Abstract][Full Text] [Related]
32. VEGF as an inhibitor of tumor vessel maturation: implications for cancer therapy.
Greenberg JI; Cheresh DA
Expert Opin Biol Ther; 2009 Nov; 9(11):1347-56. PubMed ID: 19761418
[TBL] [Abstract][Full Text] [Related]
33. Role of the low-affinity leukotriene B4 receptor BLT2 in VEGF-induced angiogenesis.
Kim GY; Lee JW; Cho SH; Seo JM; Kim JH
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):915-20. PubMed ID: 19286633
[TBL] [Abstract][Full Text] [Related]
34. Chapter 6. Mouse models to investigate anti-cancer effects of VEGF inhibitors.
Crawford Y; Ferrara N
Methods Enzymol; 2008; 445():125-39. PubMed ID: 19022058
[TBL] [Abstract][Full Text] [Related]
35. Targeting tumor angiogenesis.
Gaur P; Bose D; Samuel S; Ellis LM
Semin Oncol; 2009 Apr; 36(2 Suppl 1):S12-9. PubMed ID: 19393831
[TBL] [Abstract][Full Text] [Related]
36. VEGF as a therapeutic target in cancer.
Ferrara N
Oncology; 2005; 69 Suppl 3():11-6. PubMed ID: 16301831
[TBL] [Abstract][Full Text] [Related]
37. Vascular growth in ischemic limbs: a review of mechanisms and possible therapeutic stimulation.
van Weel V; van Tongeren RB; van Hinsbergh VW; van Bockel JH; Quax PH
Ann Vasc Surg; 2008; 22(4):582-97. PubMed ID: 18504100
[TBL] [Abstract][Full Text] [Related]
38. Pathophysiological consequences of VEGF-induced vascular permeability.
Weis SM; Cheresh DA
Nature; 2005 Sep; 437(7058):497-504. PubMed ID: 16177780
[TBL] [Abstract][Full Text] [Related]
39. Ganoderma tsugae extract inhibits expression of epidermal growth factor receptor and angiogenesis in human epidermoid carcinoma cells: In vitro and in vivo.
Hsu SC; Ou CC; Chuang TC; Li JW; Lee YJ; Wang V; Liu JY; Chen CS; Lin SC; Kao MC
Cancer Lett; 2009 Aug; 281(1):108-16. PubMed ID: 19332363
[TBL] [Abstract][Full Text] [Related]
40. Sex-steroid regulation of vascular endothelial growth factor in breast cancer.
Hyder SM
Endocr Relat Cancer; 2006 Sep; 13(3):667-87. PubMed ID: 16954424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
